Cargando…

Overview of approved CAR‐T therapies, ongoing clinical trials, and its impact on clinical practice

In recent years, we have seen rapid expansion of chimeric antigen receptor T‐cell (CAR‐T) therapies in multiple malignancies. CAR‐T therapy has profoundly altered the treatment landscape of non‐Hodgkin lymphoma, B‐cell acute lymphoblastic leukemia, and multiple myeloma. Currently available CD19 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengsayadeth, Salyka, Savani, Bipin N., Oluwole, Olalekan, Dholaria, Bhagirathbhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175669/
https://www.ncbi.nlm.nih.gov/pubmed/35844299
http://dx.doi.org/10.1002/jha2.338

Ejemplares similares